Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a BMI less than 27 kg/m2, presented at The Liver Meeting® (AASLD) 2026
A post hoc analysis of adults with MASH and liver scarring with a BMI below 27 kg/m² found that measures of liver injury, fibrosis, and disease activity improved at week 72 among participants receiving semaglutide 2.4 mg once weekly injection versus placebo Non-invasive fibrosis...
Covered in this story
Analyst targets on Badger Meter Inc
- Stifel: $126 → $150 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BMI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Badger Meter Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.